JP4537663B2 - Relaxin-like protein secretagogue - Google Patents
Relaxin-like protein secretagogue Download PDFInfo
- Publication number
- JP4537663B2 JP4537663B2 JP2003078807A JP2003078807A JP4537663B2 JP 4537663 B2 JP4537663 B2 JP 4537663B2 JP 2003078807 A JP2003078807 A JP 2003078807A JP 2003078807 A JP2003078807 A JP 2003078807A JP 4537663 B2 JP4537663 B2 JP 4537663B2
- Authority
- JP
- Japan
- Prior art keywords
- relaxin
- protein
- concentration
- semen
- sperm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は、リラキシン様蛋白質分泌促進剤により雄性動物の生殖能力を向上させる方法に関するものである。
【0002】
【従来の技術】
多くの生命体が行なう有性生殖ではオスとメスの2つの性を必要とし、それぞれが提示する配偶子の受精によって新しい世代の生命体を形成していく。言うまでもなく、生殖は生物にとってきわめて重要な生命活動である。
しかし、近年、環境ホルモン汚染などの影響でヒトの精子数減少や魚介類などで生殖能に異変が取りざたされ、生殖を取り巻く環境汚染が社会問題となっている。
【0003】
そして、牛、豚、鶏などの産業動物では、生産効率を追求するため、狭い畜舎内で集約的に飼育されることが多く、飼育管理、衛生環境面などでの改善が進められてはいるが、いまだ十分とは言えない。このような、家畜に対する様々なストレスは、繁殖成績の悪化を招き、生産効率向上の足かせとなっている。
とりわけ、養豚の分野では、集約的な生産が営まれれている外、更に、安価な畜産物の輸入圧力に加えて、家畜排泄物の規制に伴う糞尿処理の新たな負担など、養豚生産者を取巻く環境は厳しく、生産コストの削減は生産者にとって切実な問題となっている。
【0004】
生産コストの削減にとって最も重要なことは、効率的な繁殖を行ない、円滑な家畜生産を行なうことである。しかし、産業動物では、汗腺が退化しており、特に、豚などでは厚い皮下脂肪に覆われていることもあり、25℃を超える暑熱ストレスによって、何らかの繁殖障害が出ると言われている。特に種雄畜の精子数減少や精子の活力低下(運動能の低下)などの精液性状の異常をきたし、しばしば繁殖障害の原因となっている。
このような問題を解決する方法として、例えば、オリゴ糖、特にフラクトオリゴ糖を主成分とする糖類を含有する種豚用飼料を用いることを特徴とする雄豚の生殖能力を向上させる方法が知られているが(例えば、特許文献1参照)、十分であるとは言い難い。
【0005】
また、体外受精においては、精子の受精能が不十分であるため、運動性を高めるためカフェインやβ−サイクロデキストリンを添加することが知られている。しかしながら、これらの方法では、多精子進入が起こるなど正常な受精卵が得られる確率は低かった。そこで、特定のペプチドを精子に添加して運動性を高めることで受精率を向上させる方法も開発されている。
このような方法としては、例えば、受精前に精巣−特異的インシュリン同族体ペプチドを、精子に添加して運動性を高める方法(例えば、特許文献2参照)やバッファロー血精/血漿由来の精子運動能促進性高分子タンパク質(例えば、特許文献3参照)が知られている。
しかし、これらのペプチドを作るためには、遺伝子組換え技術やタンパク質を得るための生体が不可欠であること、純度を高めるため精製しなければならないこと、また体外受精を行う必要があること等、極めて煩雑でコストの高い方法であった。
【0006】
リラキシンは、妊娠期の生殖器に見出される妊娠ホルモンの一つである。
一方、リラキシン様蛋白質は、リラキシンと相同性のあるペプチドホルモンであり、雄性動物類の精漿中に含まれている。リラキシン様蛋白質は、精子のレセプターに結合してその運動性を高めると考えられている。即ち、射精時に精子の先体に主に結合し,150〜200μg/mlの濃度で精巣上体尾部精子に暴露させると顕著に受精能獲得や先体反応を誘起するとされている(例えば、非特許文献1、非特許文献2参照)。
このようなリラキシン様蛋白質としては、例えば、ブタ精漿腺から単離された分子量約13kDaの分泌蛋白質があり、10頭の種豚について精漿リラキシン様蛋白質濃度を調べた結果、117−700μg/ml(平均300±170μg/ml)であった(例えば、非特許文献3参照)。
【0007】
【特許文献1】
特開平8−205789号公報
【特許文献2】
特開2002−204698号公報
【特許文献3】
特開平11−279075号公報
【非特許文献1】
Journal of Reproduction and Development、Vol.47、No.4、2001、197-204
【非特許文献2】
「2001年度日本畜産学会第98回大会講演要旨」、社団法人日本畜産学会、p.109
【非特許文献3】
「2001年第94回日本繁殖生物学会講演要旨」、日本繁殖生物学会、p.88
【0008】
また、最近、顕微鏡での検査では精子数や精子の活力(運動性)は正常であっても、卵子との受精能の低い、低受胎性精液の存在が知られている。この原因は、まだはっきりと解明されていないが、精子核のストレスに対する抵抗性が低いことや精子頭部の首振り振幅幅の小さいことが原因と見られている。
繁殖動物の管理では、精液の性状は熟練を要し手間のかかる顕微鏡観察や、実際に雌性動物で発情の有無を調べたり、超音波検査機器など高価な電子機器が必要とする。ここで雌性動物での判断は、個体の影響が大きいため、受胎率や産子数などで精液に問題があっても発見することは非常に困難があった。
従って、長期に渡って精液性状に異常のある種雄畜を使用することになるため、経済的な損失は大きい。このため、従来の顕微鏡を用いた判定では発見できない種雄畜の精液異常を早期に発見できれば、経済的な損失は最小限で食い止めることが出来る。
以上のことから、雄性動物の生殖能力を向上させる方法の開発が待たれている。
【0009】
【発明が解決しようとする課題】
本発明の目的は、精液中のリラキシン様蛋白質濃度を増加させ、雄性動物の生殖能力を高める方法を提供することにある。
【0010】
【課題を解決するための手段】
本発明者らは、リラキシン様蛋白質が精子に運動性を付与する錠分子であると考え、上記の課題を解決するべく鋭意研究を重ねたところ、オリゴ糖とリラキシン様蛋白質の分泌との間には関係があることを知り、更に研究を重ねた結果、本発明を完成するに至った。
【0011】
即ち、本発明は、以下のとおりである。
1.精漿中のリラキシン様蛋白質が300μg/ml未満の雄豚に対して、イソマルトオリゴ糖を0.01g〜0.3g/日/体重kg投与することにより、精漿中のリラキシン様蛋白質を300μg/ml以上に高めることを特徴とする雄豚の精漿中のリラキシン様蛋白質濃度を高める方法。
2.精漿中のリラキシン様蛋白質濃度を測定し、精漿中のリラキシン様蛋白質が300μg/ml以上である場合を適性であると判断することを特徴とする雄豚の精液の正常度の判別法。
【0012】
本発明は、オリゴ糖には優れたリラキシン様蛋白質分泌促進作用があるという、本発明により初めて見出された新事実の発見に基づいてなされたものである。本発明によれば、オリゴ糖の作用によりリラキシン様蛋白質の分泌が促進される結果、精液中のリラキシン様蛋白質の濃度低下が防止されるので、牛、豚、鶏などの雄性動物においても暑熱ストレスなどの環境変化による精子活力の低下を引き起こすことがなく、農場成績を向上・安定させるという、格別の効果が達成される。
また、従来の顕微鏡を用いた判定では発見できなかった雄豚等の精液異常を精液中のリラキシン様蛋白質の濃度を測定することにより、早期に発見できるので、経済的な損失は最小限で食い止めることが出来る。
【0013】
以下、本発明について、更に詳細に説明する。
本発明のオリゴ糖としては、イソマルトオリゴ糖、ガラクトオリゴ糖、フラクトオリゴ糖、大豆オリゴ糖、ラフイノース、キシロオリゴ糖、ラクチュロース、ラクトスクロース等が挙げられるが、特に、イソマルトース、イソマルトリオース、パノースなど、グルコースがα−1,4結合以外の結合を有するオリゴ糖、例えば、イソマルトオリゴ糖が最適である。
イソマルトオリゴ糖は、熱や酸に対する安定性が高いため、飼料の加熱処理や酸性剤の添加等による失活が少ないので、イソマルトオリゴ糖からなるリラキシン様蛋白質分泌促進剤は、その使用が制限されない点でも有利である。
【0014】
受精率の高い精液を繁殖に使用するためには、一定基準のリラキシン様蛋白質濃度を超える精液を使用する必要がある。
その基準は、実際に、リラキシン様蛋白質濃度を測定して、人工授精により、受胎率を測定することができる(補足的なデータとして、運動精子率などの精子の運動性も同時に測定してもよい)。実際に分娩率、出生率で生殖能力を調べる方法もあるが、判定に多大な時間、例えば、妊娠期間は牛で280日、豚で144日を要する上に、母胎の影響が大きく、N数を大きくする必要がある。
【0015】
判断基準は種によって異なり、血統が守られている動物などでも異なる。また、繁殖時期によっても異なる。
豚の場合は、精漿中のリラキシン様蛋白質が280μg/ml以上、望ましくは300μg/ml以上がよい。リラキシン様蛋白質が240μg/ml以下の精液は、不良精液と判断し、使用しないのがよい。
【0016】
本発明のリラキシン様蛋白質分泌促進剤は、オリゴ糖を単独、或いは、他の添加物、例えば、賦形剤、崩壊剤、栄養剤、ハーブ(生薬)等の成分が含まれていてもよい。
賦形剤としては、ケイ酸、ゼオライト、炭酸カルシウム、リン酸カルシウム、糖(ラクトース、スクロース、マンニトール、ソルビトール等)、澱粉(トウモロコシ澱粉、小麦澱粉、米澱粉、ジャガイモ澱粉等)、セルロース誘導体(メチルセルロース、ヒドロキシプロピルメチルセルロース、ナトリウムカルボキシメチルセルロース、ポリビニルピロリドン等)、ゼラチン、トラガントゴム等が、崩壊剤としては、架橋ポリビニルピロリドン、寒天、アルギン酸又はその塩等が、栄養剤としては、アミノ酸、ビタミン等が、それぞれ挙げられる。
【0017】
本発明のリラキシン様蛋白質分泌促進剤は、ヒトや豚、牛、馬、羊、山羊、鶏等の産業動物、また、イヌ、ネコなどの愛玩動物等でその効果が認められ、食品、飼料、医薬品等に添加することにより使用することができる。
本発明のリラキシン様蛋白質分泌促進剤の添加量は、有効成分であるオリゴ糖として、0.01g〜0.3g/日/体重kg程度で効果が認められるが、望ましくは0.02g〜0.2g/日/体重kgが良い。
また、オリゴ糖の機能は主に腸内細菌叢のバランス良化によるところが大きいと考えられるので、本分泌促進剤は継続的に連続して給与することが望ましいが、豚などの夏場対策として季節限定で用いるならば、夏場に入る2〜3ケ月前から給与しても良い。
【0018】
【発明の実施の形態】
以下、実施例を挙げて本発明を具体的に説明するが、これらは本発明を限定するものではない。
1.精漿中のリラキシン様蛋白質濃度の測定
リラキシン様蛋白質濃度の測定は、リラキシン濃度の測定法として確立されている時間分解蛍光免疫測定法に準じて行った(例えば、非特許文献4参照)。
【0019】
【非特許文献4】
「臨床獣医」臨時増刊号、Vol.20、No.3、2002、P.151-159
【0020】
(1)トレーサーの作成
精製したリラキシン様蛋白質を用い、非放射性蛍光物質ユーロピウムで標識した後、ゲル濾過による分画を行い、ユーロピウムで標識されたリラキシン様蛋白質を得る。
【0021】
(2)リラキシン様蛋白質特異抗体の作成
リラキシン様蛋白質特異抗体はウサギに免疫して作製する。
得られた抗体は、リラキシン様蛋白質とのみクロスリアクションするが、精嚢膿抽出液の中の他の成分とはクロスリアクションしないこと、また、インスリンやFSHともクロスリアクションしないことから、リラキシン様蛋白質に特異的な抗体であることを確認する。
【0022】
(3)時間分解蛍光免疫測定法(TR-FIA)
第二抗体を固相化した競合的原理に基づく、時間分解蛍光免疫測定法を用いて、以下の方法により、精漿中のリラキシン様蛋白質濃度を測定した。
第二抗体を固相化したマイクロタイタープレートにサンプルまたはスタンダードと第一抗体を加え、1.5時間インキュベーションする。次いで、トレーサーとしてユーロピウム標識リラキシン様蛋白質を加え、さらに3.5時間、インキュベーションする。インキュベーション終了後、プレートを6回洗浄し反応を停止する。その後、標識リラキシン様蛋白質からユーロピウムイオンが遊離し、高い蛍光を示すキレート化合物を形成させるための増強試薬(Na N3)を添加する。5分間インキュベーションした後、時間分解蛍光装置で蛍光をカウントする。
【0023】
【実施例1】
有効成分87.5%イソマルトオリゴ糖を含むシロップ(イソマルト900:昭和産業株式会社製)69部に、賦形剤としてケイ酸(United Silica Industrial Ltd.製)31部を噴霧乾燥して、リラキシン様蛋白質分泌促進剤を調整した。
上記のリラキシン様蛋白質分泌促進剤を人工授精用の雄豚に給与し、無添加の対照区と比較しながら、精漿中のリラキシン様蛋白質濃度の経時的な推移を調査した。
【0024】
(1)試験方法
人工授精用の種雄豚20頭を10頭ずつ添加区と対照区に分け、添加区には上記の本発明の分泌促進剤を、イソマルトオリゴ糖として、25g/日/豚体重約250kg給与し、対照区は無給与とした。試験期間は、雄豚の夏場対策を想定し、4〜10月までの7ケ月間とした。
【0025】
(2)調査項目
試験期間中、精液は約1回/週のペースで採取し、顕微鏡で採取精液を観察してその性状を調査するとともに、1回/月のペースで採取精漿中のリラキシン様蛋白質の濃度を測定した。
【0026】
(3)試験結果
1)精子の性状
対照区では、供試豚10頭のうち2頭が9月から精液性状に異常が見られ、廃豚となった。これに対して、添加区の供試豚は、試験期間中、精液の性状に異常は見られず良好であった。
【0027】
2)リラキシン様蛋白質の濃度
濃度の測定結果は、表1に示す。
【0028】
【表1】
数値:平均±標準誤差 単位:μg/ml
【0029】
表1によると、精漿中のリラキシン様蛋白質の濃度は、試験後半の8月以降、添加区が対照区を上回る数値を示した。
上記の結果から、本分泌促進剤は、雄豚の精漿中のリラキシン様蛋白質濃度を増加させることが解る。
また、上記の試験データについて、元々リラキシン様蛋白質の濃度が低い各豚5頭のデータを示すと、表2の結果となる。
【0030】
【表2】
数値:平均±標準誤差 単位:μg/ml
【0031】
表2の結果から、添加区では300μg/mlまで回復しており、添加区と対照区を比較すると、特に7〜10月での差が大きく、本分泌促進剤は、元々リラキシン様蛋白質の濃度が低い豚に特に有効であることが解る。
以上の結果、本発明の分泌促進剤は、雄豚の精漿中のリラキシン様蛋白質濃度を増加させ高めることが確認された。
【0032】
【実施例2】
11頭の種豚から精漿を集め、リラキシン様蛋白質濃度を測定した。平均リラキシン様蛋白質濃度は、300μg/mlであった。平均濃度を基準にして高リラキシン様蛋白質濃度区(8頭)と低リラキシン様蛋白質濃度区(3頭)の二つのグループに分けた。高リラキシン様蛋白質濃度区のリラキシン様蛋白質の平均濃度は346μg/mlであり、低濃度区リラキシン様蛋白質平均濃度は174μg/mlであった。各濃度区の種豚の精子の性状並びに対外受精率を測定した。結果は、表3に示す。
【0033】
【表3】
RLP:リラキシン様蛋白質 数値:平均±標準偏差
【0034】
表3の結果では、顕微鏡下で評価する運動精子率、生存精子率、未成熟精子率に有意差は見られなかった。
それに対して、実際に、卵子を使用している体外受精率測定では、高リラキシン様蛋白質濃度区と低リラキシン様蛋白質濃度区で、明確な差が認められた。
このように、従来行われていた顕微鏡下で観察する方法による評価では、正常精液の判別が難しく、精漿中のリラキシン様蛋白質濃度を測定することで初めて判別することができることが解った。
【0035】
以上の実施例1及び実施例2の結果から、オリゴ糖は、リラキシン様蛋白質の分泌を促進させ、雄豚の生殖能力を向上させることが解る。
そして、従来の技術では、精子の運動能で問題のない精液を用いて人工授精しても十分な繁殖成績が得られないことがあったが、精漿中のリラキシン様蛋白質濃度を測定することで、生殖能力の高い精液を判別出来ることが可能となった。
【0036】
【発明の効果】
(1)本発明によれば、リラキシン様蛋白質の分泌が促進される結果、精漿中のリラキシン様蛋白質の濃度低下が防止されるので、牛、豚、鶏などの雄性動物においても暑熱ストレスなどの環境変化による精子活力の低下を引起こすことがなく、農場成績を向上・安定させるという、格別の効果が達成される。また、イヌ、ネコなどの愛玩動物では、精漿中のリラキシン様蛋白質を増加させ、円滑な繁殖が可能となる。
【0037】
(2)従来の顕微鏡を用いた判定では発見できなかった雄豚等の精液異常を精漿中のリラキシン様蛋白質の濃度を測定することにより、早期に発見できるので、経済的な損失は最小限で食い止めることが出来る。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a method for improving the fertility of a male animal with a relaxin-like protein secretion promoter.
[0002]
[Prior art]
Sexual reproduction performed by many life forms requires two sexes, male and female, and forms a new generation of life forms by fertilization of the gametes presented by each. Needless to say, reproduction is a vital activity of life.
However, in recent years, there has been a change in fertility due to a decrease in the number of human spermatozoa and seafood due to the effects of environmental hormone contamination, and environmental pollution surrounding reproduction has become a social problem.
[0003]
And in order to pursue production efficiency, industrial animals such as cattle, pigs, and chickens are often bred intensively in a small barn, and improvements are being promoted in terms of breeding management and sanitary environment. But still not enough. Such various stresses on livestock cause deterioration of the reproductive performance and hinder production efficiency.
In particular, in the field of pig farming, in addition to the intensive production, in addition to the import pressure of cheap livestock products, the new burden of manure processing due to the regulation of livestock excrement has been added. The surrounding environment is severe, and the reduction of production costs is a serious problem for producers.
[0004]
The most important thing for reducing production costs is to carry out efficient breeding and smooth livestock production. However, in industrial animals, sweat glands are degenerated, and pigs and the like are particularly covered with thick subcutaneous fat, and it is said that some kind of reproductive disorder is caused by heat stress exceeding 25 ° C. In particular, semen properties such as a decrease in the number of sperm in bred animals and a decrease in sperm vitality (decreased motility) have been caused, often causing reproductive disorders.
As a method for solving such a problem, for example, a method for improving the reproductive performance of a boar characterized by using a feed for seed pigs containing oligosaccharides, particularly saccharides mainly containing fructooligosaccharides, is known. However, it is difficult to say that it is sufficient (see, for example, Patent Document 1).
[0005]
In addition, in vitro fertilization, since sperm fertility is insufficient, it is known to add caffeine or β-cyclodextrin to enhance motility. However, these methods have a low probability of obtaining a normal fertilized egg such as the occurrence of multisperm entry. Thus, a method for improving the fertilization rate by adding a specific peptide to sperm to enhance motility has been developed.
As such a method, for example, a testis-specific insulin homolog peptide is added to sperm before fertilization to enhance motility (for example, refer to Patent Document 2), or buffalo semen / plasma-derived sperm movement. An ability promoting polymer protein (for example, see Patent Document 3) is known.
However, in order to make these peptides, it is indispensable to have a living body for obtaining a genetic recombination technique or protein, it must be purified to increase purity, and it is necessary to perform in vitro fertilization, It was an extremely complicated and expensive method.
[0006]
Relaxin is one of the pregnancy hormones found in the genitals during pregnancy.
On the other hand, relaxin-like protein is a peptide hormone homologous to relaxin and is contained in the seminal plasma of male animals. Relaxin-like proteins are thought to bind to sperm receptors and increase their motility. That is, it mainly binds to the sperm acrosome at the time of ejaculation, and if it is exposed to epididymis tail sperm at a concentration of 150 to 200 μg / ml, it is said to significantly induce fertility and acrosome reaction (for example, non (See Patent Document 1 and Non-Patent Document 2).
As such relaxin-like protein, for example, there is a secretory protein having a molecular weight of about 13 kDa isolated from porcine seminal gland. As a result of examining the concentration of seminal plasma relaxin-like protein in 10 breed pigs, 117-700 μg / ml (average 300 ± 170 μg / ml) (see, for example, Non-Patent Document 3).
[0007]
[Patent Document 1]
JP-A-8-205789 [Patent Document 2]
JP 2002-204698 A [Patent Document 3]
JP-A-11-279075 [Non-patent Document 1]
Journal of Reproduction and Development, Vol.47, No.4, 2001, 197-204
[Non-Patent Document 2]
“Abstracts of the 98th Annual Meeting of the Japanese Society of Livestock Science 2001”, Japan Society of Animal Science, p.109
[Non-Patent Document 3]
"Abstracts of the 94th Annual Meeting of the Japanese Reproductive Biology Society" 2001, Japanese Reproductive Biology Society, p.88
[0008]
Recently, it has been known that low fertility semen having a low fertility with an egg is known even when the number of sperm and vitality (motility) of sperm are normal by microscopic examination. Although this cause has not been clearly clarified yet, it is considered that the resistance to stress of the sperm nucleus is low and the swing amplitude width of the sperm head is small.
In the management of breeding animals, the characteristics of semen require skillful and time-consuming microscopic observation, and in fact, female animals are examined for the presence or absence of estrus, and expensive electronic equipment such as ultrasonic examination equipment is required. Here, the determination in female animals is very difficult to find even if there is a problem with semen, such as the conception rate or the number of offspring, because the influence of the individual is great.
Therefore, since a sire with abnormal semen properties is used for a long time, economic loss is great. For this reason, if a semen abnormality of a breeding sire that cannot be found by a determination using a conventional microscope can be discovered at an early stage, economic loss can be minimized.
From the above, development of a method for improving the fertility of male animals is awaited.
[0009]
[Problems to be solved by the invention]
It is an object of the present invention to provide a method for increasing the reproductive performance of male animals by increasing the concentration of relaxin-like protein in semen.
[0010]
[Means for Solving the Problems]
The present inventors consider that relaxin-like protein is a tablet molecule that imparts motility to sperm, and as a result of intensive research to solve the above-mentioned problems, between the oligosaccharide and the secretion of relaxin-like protein, Knew that there was a relationship, and as a result of further research, the present invention was completed.
[0011]
That is, the present invention is as follows.
1. By administering 0.01-0.3 g / day / kg body weight of isomaltoligosaccharide to a boar with a relaxin-like protein of less than 300 μg / ml in seminal plasma, 300 μg / kg of relaxin-like protein in seminal plasma is administered. A method for increasing the concentration of relaxin-like protein in the seminal plasma of boar, characterized by increasing to more than ml.
2. A method for discriminating the normality of semen of a boar characterized by measuring the concentration of relaxin-like protein in seminal plasma and determining that the relaxin-like protein in seminal plasma is 300 μg / ml or more as appropriate.
[0012]
The present invention has been made on the basis of the discovery of a new fact first discovered by the present invention that oligosaccharides have an excellent relaxin-like protein secretion-promoting action. According to the present invention, the secretion of relaxin-like protein is promoted by the action of the oligosaccharide, and as a result, the concentration of relaxin-like protein in semen is prevented from decreasing, so that heat stress can also occur in male animals such as cattle, pigs and chickens. A special effect of improving and stabilizing the farm performance is achieved without causing a decrease in sperm vitality due to environmental changes.
In addition, abnormalities in semen, such as boars, that could not be detected using conventional microscopes can be detected at an early stage by measuring the concentration of relaxin-like protein in semen. I can do it.
[0013]
Hereinafter, the present invention will be described in more detail.
Examples of the oligosaccharide of the present invention include isomaltoligosaccharide, galactooligosaccharide, fructooligosaccharide, soybean oligosaccharide, raffinose, xylo-oligosaccharide, lactulose, lactosucrose and the like, in particular, isomaltose, isomaltlyose, panose, Oligosaccharides in which glucose has bonds other than α-1,4 bonds, for example, isomaltoligosaccharides, are optimal.
Since isomaltooligosaccharides are highly stable against heat and acid, there is little inactivation due to heat treatment of feed or addition of acidic agents, so the use of relaxin-like protein secretion promoters consisting of isomaltooligosaccharides is not limited This is also advantageous.
[0014]
In order to use semen with a high fertilization rate for reproduction, it is necessary to use semen that exceeds a certain standard relaxin-like protein concentration.
The standard is that you can actually measure the relaxin-like protein concentration and measure the conception rate by artificial insemination (as a supplementary data, you can also measure the sperm motility such as the rate of sperm. Good). There is actually a method to check fertility by the birth rate and birth rate, but it takes a lot of time for judgment, for example, pregnancy period is 280 days for cattle and 144 days for pigs. It needs to be bigger.
[0015]
Judgment criteria vary depending on the species, and also for animals with protected pedigree. It also varies depending on the breeding season.
In the case of pigs, the relaxin-like protein in seminal plasma is 280 μg / ml or more, preferably 300 μg / ml or more. Semen with a relaxin-like protein of 240 μg / ml or less is judged to be defective semen and should not be used.
[0016]
The relaxin-like protein secretion promoter of the present invention may contain oligosaccharides alone or other additives such as excipients, disintegrants, nutrients, herbs (herbal medicines) and the like.
Excipients include silicic acid, zeolite, calcium carbonate, calcium phosphate, sugar (lactose, sucrose, mannitol, sorbitol, etc.), starch (corn starch, wheat starch, rice starch, potato starch, etc.), cellulose derivatives (methylcellulose, hydroxy) Propylmethylcellulose, sodium carboxymethylcellulose, polyvinylpyrrolidone, etc.), gelatin, tragacanth rubber, etc., disintegrating agents include cross-linked polyvinylpyrrolidone, agar, alginic acid or salts thereof, and nutrients include amino acids, vitamins, etc. .
[0017]
The relaxin-like protein secretagogue of the present invention has been found to be effective in industrial animals such as humans, pigs, cows, horses, sheep, goats and chickens, and pets such as dogs and cats. It can be used by adding to pharmaceuticals.
The effect of the relaxin-like protein secretion promoter of the present invention is about 0.01 g to 0.3 g / day / kg body weight as an active ingredient oligosaccharide, but preferably 0.02 g to 0. 2g / day / kg body weight is good.
In addition, since the function of oligosaccharides is thought to be mainly due to the improved balance of the intestinal microflora, it is desirable to continuously supply this secretagogue, but as a summer measure for pigs, etc. If it is used in a limited way, you may pay 2 to 3 months before entering the summer.
[0018]
DETAILED DESCRIPTION OF THE INVENTION
EXAMPLES Hereinafter, the present invention will be specifically described with reference to examples, but these do not limit the present invention.
1. Measurement of relaxin-like protein concentration in seminal plasma The relaxin-like protein concentration was measured according to a time-resolved fluorescence immunoassay established as a method for measuring relaxin concentration (see, for example, Non-Patent Document 4).
[0019]
[Non-Patent Document 4]
"Clinical Veterinary" special issue, Vol.20, No.3, 2002, P.151-159
[0020]
(1) Preparation of tracer Using a purified relaxin-like protein and labeling with a non-radioactive fluorescent substance europium, fractionation by gel filtration is performed to obtain a relaxin-like protein labeled with europium.
[0021]
(2) Preparation of relaxin-like protein specific antibody Relaxin-like protein specific antibody is prepared by immunizing rabbits.
The resulting antibody cross-reacts only with relaxin-like protein, but does not cross-react with other components in seminal pus extract, and does not cross-react with insulin or FSH. Confirm that it is a specific antibody.
[0022]
(3) Time-resolved fluorescence immunoassay (TR-FIA)
Using a time-resolved fluorescence immunoassay based on a competitive principle in which the second antibody was immobilized, the relaxin-like protein concentration in seminal plasma was measured by the following method.
The sample or standard and the first antibody are added to the microtiter plate on which the second antibody is immobilized, and incubated for 1.5 hours. Subsequently, europium labeled relaxin-like protein is added as a tracer and incubated for an additional 3.5 hours. After the incubation is complete, the plate is washed 6 times to stop the reaction. Thereafter, an europium ion is released from the labeled relaxin-like protein, and an enhancement reagent (Na N 3 ) for forming a chelate compound exhibiting high fluorescence is added. After incubation for 5 minutes, the fluorescence is counted with a time-resolved fluorescence apparatus.
[0023]
[Example 1]
69 parts of syrup containing 87.5% isomaltoligosaccharide (Isomalt 900: made by Showa Sangyo Co., Ltd.) and 31 parts of silicic acid (made by United Silica Industrial Ltd.) as an excipient are spray-dried. A protein secretagogue was prepared.
The above relaxin-like protein secretion promoter was fed to a boar for artificial insemination, and the time course of the relaxin-like protein concentration in seminal plasma was investigated while comparing with the control group without addition.
[0024]
(1) Test method Twenty male boars for artificial insemination are divided into an added group and a control group, each containing 25 g / day / pig body weight as the above-mentioned secretagogue of the present invention as an isomaltooligosaccharide. About 250kg was paid, and the control ward was unpaid. The test period was 7 months from April to October, assuming summer measures for boars.
[0025]
(2) Survey items During the test period, semen is collected at a rate of about once / week, the collected semen is observed with a microscope to investigate its properties, and relaxin in the seminal plasma collected at a rate of once / month. The concentration of the like protein was measured.
[0026]
(3) Test results 1) Sperm properties In the control group, 2 out of 10 test pigs showed abnormal semen properties from September and became swine. In contrast, the test pigs in the addition group were good with no abnormal semen properties during the test period.
[0027]
2) Table 1 shows the measurement results of the concentration of relaxin-like protein.
[0028]
[Table 1]
Numerical value: Mean ± standard error Unit: μg / ml
[0029]
According to Table 1, the concentration of relaxin-like protein in seminal plasma showed a value that the added group exceeded the control group after August in the latter half of the test.
From the above results, it is understood that the present secretagogue increases the concentration of relaxin-like protein in the seminal plasma of boars.
In addition, regarding the above test data, the data of 5 pigs each originally having a low concentration of relaxin-like protein are shown in Table 2.
[0030]
[Table 2]
Numerical value: Mean ± standard error Unit: μg / ml
[0031]
From the results of Table 2, in the added group, it was recovered to 300 μg / ml. When the added group and the control group were compared, the difference was particularly large in July to October, and the secretagogue was originally a relaxin-like protein concentration. It can be seen that it is particularly effective for low pigs.
As a result, it was confirmed that the secretagogue of the present invention increases and increases the concentration of relaxin-like protein in the seminal plasma of boars.
[0032]
[Example 2]
Seminal plasma was collected from 11 sows and the relaxin-like protein concentration was measured. The average relaxin-like protein concentration was 300 μg / ml. Based on the average concentration, it was divided into two groups, a high relaxin-like protein concentration group (8 heads) and a low relaxin-like protein concentration group (3 heads). The average concentration of relaxin-like protein in the high relaxin-like protein concentration group was 346 μg / ml, and the average concentration of relaxin-like protein in the low concentration group was 174 μg / ml. The sperm properties and the external fertilization rate of the pigs in each concentration group were measured. The results are shown in Table 3.
[0033]
[Table 3]
RLP: Relaxin-like protein Value: Mean ± standard deviation
In the results of Table 3, no significant difference was observed in the motor sperm rate, viable sperm rate, and immature sperm rate evaluated under a microscope.
In contrast, in vitro fertilization rate measurement using eggs, a clear difference was observed between the high relaxin-like protein concentration group and the low relaxin-like protein concentration group.
Thus, it has been found that the conventional evaluation by the method of observing under a microscope makes it difficult to discriminate normal semen, and it can be discriminated for the first time by measuring the concentration of relaxin-like protein in seminal plasma.
[0035]
From the results of Examples 1 and 2 above, it can be seen that oligosaccharides promote the secretion of relaxin-like proteins and improve the reproductive performance of boars.
And with the conventional technology, even if artificial insemination was not possible even with artificial insemination using semen that has no problem with sperm motility, the concentration of relaxin-like protein in seminal plasma should be measured. This makes it possible to discriminate semen with high fertility.
[0036]
【The invention's effect】
(1) According to the present invention, since the secretion of relaxin-like protein is promoted, the concentration of relaxin-like protein in seminal plasma is prevented from decreasing, so that heat stress and the like can be observed in male animals such as cows, pigs and chickens. A special effect of improving and stabilizing the farm performance is achieved without causing a decrease in sperm vitality due to environmental changes. Moreover, in pet animals such as dogs and cats, relaxin-like protein in seminal plasma is increased and smooth breeding becomes possible.
[0037]
(2) Since semen abnormalities such as boars that could not be detected by conventional microscopy can be detected early by measuring the concentration of relaxin-like protein in seminal plasma, economic loss is minimal. You can stop at.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003078807A JP4537663B2 (en) | 2003-03-20 | 2003-03-20 | Relaxin-like protein secretagogue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003078807A JP4537663B2 (en) | 2003-03-20 | 2003-03-20 | Relaxin-like protein secretagogue |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004284980A JP2004284980A (en) | 2004-10-14 |
JP4537663B2 true JP4537663B2 (en) | 2010-09-01 |
Family
ID=33293182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003078807A Expired - Lifetime JP4537663B2 (en) | 2003-03-20 | 2003-03-20 | Relaxin-like protein secretagogue |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4537663B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112273319A (en) * | 2019-07-24 | 2021-01-29 | 茶陵白洲生态种养专业合作社 | Pig ecological breeding method |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104206810A (en) * | 2014-07-25 | 2014-12-17 | 安徽金源农牧科技有限公司 | Breeding boar feed and preparation method thereof |
CN107318782B (en) * | 2017-08-24 | 2020-12-25 | 凤庆县绿康牧业有限公司 | A kind of breeding method of ecological pig under forest |
CN108377964A (en) * | 2018-01-30 | 2018-08-10 | 广西东兰县隘洞拉社通达种养专业合作社 | A kind of breeding method of hybridized pig |
CN112602664B (en) * | 2020-12-10 | 2023-04-25 | 贵州铜仁厚聚农业科技开发服务有限公司 | Breeding method for improving disease resistance of live pigs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3174470B2 (en) * | 1995-02-03 | 2001-06-11 | 明治製菓株式会社 | How to improve the reproductive performance of boars using breeding pig feed |
AU3972797A (en) * | 1996-08-02 | 1998-02-25 | Zymogenetics Inc. | Testis-specific insulin homolog polypeptides |
-
2003
- 2003-03-20 JP JP2003078807A patent/JP4537663B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112273319A (en) * | 2019-07-24 | 2021-01-29 | 茶陵白洲生态种养专业合作社 | Pig ecological breeding method |
Also Published As
Publication number | Publication date |
---|---|
JP2004284980A (en) | 2004-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Prunier et al. | High physiological demands in intensively raised pigs: impact on health and welfare | |
Hammond | Further observations on the factors controlling fertility and foetal atrophy | |
US6183769B1 (en) | Methods of enhancing reproductive performance of animals | |
Atashi et al. | Trends in the reproductive performance of Holstein dairy cows in Iran | |
da Costa et al. | Hormonal profiles, physiological parameters, and productive and reproductive performances of Girolando cows in the state of Ceará-Brazil | |
Hudaya et al. | Behavior and blood profile in Friesian-Holstein dairy cows in the special region of Yogyakarta, Indonesia | |
JP4537663B2 (en) | Relaxin-like protein secretagogue | |
Hamid et al. | Effects of GnRH on conception rate at the time of artificial insemination in crossbred dairy cows | |
JP3721439B2 (en) | High lactation breeding methods using rumen-protected amino acids | |
Abdullahoğlu et al. | Factors affecting colostrum quality and calf passive transfer levels in Holstein cattle. | |
Al-Najjar et al. | Evaluation of some productive characteristics of Jordanian Awassi | |
Hailu et al. | Effects of gonadotropin releasing hormone analogue in enhancements of pregnancy in repeat breeding dairy cows in and around Mekelle, Tigray, Ethiopia | |
Volkmann et al. | Impacts of prepubertal rearing intensity and calf health on first-lactation yield and lifetime performance | |
ZEBARI | Factors that influence on reproductive efficiency in karadi and awassi sheep raised under traditional conditions | |
Tyagi et al. | Lameness in crossbred cows: Its effect on productive and reproductive performance | |
Barth | Case-based studies of infertility in bulls | |
Yusuf et al. | Analysis of some factors affecting fertility levels in a high‐producing dairy herd in south‐western Japan | |
Sivaraman et al. | Blood profile constituents associated with production diseases in Jersey crossbred cows | |
Demis et al. | On farm trial of prostaglandin based estrus synchronization protocols in selected milk-shed areas of Amhara Region, Ethiopia | |
Carcangiu et al. | Blood parameters during lactation and dry period in sarda sheep breed | |
Sood et al. | Lameness in crossbred cows: Prevalence, host level risk factors and reproductive performance | |
Zhou et al. | Characterization of the physical and ruminal activities related to estrus in dairy cows raised on Chinese commercial farms | |
Pruitt et al. | Effect of Calving Time and Weaning Time on Cow and Calf Performace-A Preliminary Report | |
Morini et al. | Effects of chronic melatonin administration on pregnancy rate in dairy cows submitted to a fixed-time AI protocol during summer and winter seasons. | |
Dire et al. | Survival and Development of in Vivo Produced Boran and Boran* Holstein Cross Embryos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060207 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091110 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100108 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100309 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100601 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100528 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100618 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130625 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4537663 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |